ATF Form 4473 Drops Marijuana Warning for Gun Buyers

For the first time in more than a decade, federal firearms buyers will see a Form 4473 that does not explicitly warn medical marijuana patients that they cannot lawfully purchase a gun. The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) published a draft revision to Form 4473 in early May 2026 that strikes the long-standing medical cannabis disclaimer, a quiet but consequential downstream effect of the Trump administration's April 23 rescheduling order moving FDA-approved and state-licensed medical marijuana products to Schedule III.

The proposed change does not legalize recreational marijuana use for firearm purchasers, and gun buyers will still be required to certify they are not an unlawful user of, or addicted to, marijuana. But the explicit caution that "the use or possession of marijuana remains unlawful under Federal law regardless of whether it has been legalized or decriminalized for medicinal or recreational purposes in the state where you reside" has been removed from the medical context.

What the ATF Actually Changed in Form 4473

The current Form 4473, used by every federally licensed firearms dealer in the country, asks buyers whether they are "an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance." That language has historically been paired with a bolded warning that medical marijuana — even when used legally under a state program — was disqualifying.

The draft revision narrows the implication. According to a notice in the Federal Register, the updated form keeps marijuana in the controlled-substance question but drops the explicit medical-marijuana warning, narrowing the disclaimer's focus to recreational cannabis use. ATF is also using the revision to remove the non-binary sex option and to clarify straw-purchase language, in line with broader Trump administration directives on firearm regulation.

ATF is accepting public comments on the revised gun purchase form through July 7, 2026. After comments close, the bureau will finalize the form and require dealers to begin using it on a date to be announced.

Why Schedule III Changed the Math

The rescheduling order signed on April 23, 2026, and codified by the Department of Justice on April 29 moved FDA-approved cannabis products and qualifying state-licensed medical marijuana products from Schedule I to Schedule III of the Controlled Substances Act. That means medical cannabis, when dispensed under a qualifying state license, is no longer treated as a substance with "no currently accepted medical use" — the exact federal posture that has long blocked cardholding patients from passing a Form 4473 background check.

A Congressional Research Service report published in early May noted that "certified patients who possess medical marijuana from state-licensed dispensaries now have certain protections under Schedule III," and that the order "appears to authorize end users to possess marijuana for medical use without a CSA-compliant prescription." That regulatory shift gave ATF the cover it needed to soften the form's medical-cannabis disclaimer without congressional action.

Even so, the White House drug czar reiterated in May that "marijuana is still illegal" at the federal level for non-medical purposes — a signal that the ATF revision is narrow, not sweeping. Recreational consumers in adult-use states remain federally prohibited from purchasing or possessing firearms.

Who Benefits and Who Still Cannot Buy a Gun

The new Form 4473 will primarily benefit state-registered medical cannabis patients in the 38 jurisdictions with medical programs. For an estimated 6 million to 7 million registered patients nationwide, the practical question of whether to surrender a firearm to maintain a medical card has, for the first time in years, a more permissive federal answer.

Several categories of cannabis consumer remain barred from passing a Form 4473 background check. Adult-use recreational consumers in legal states are still considered "unlawful users" under federal definitions and must answer accordingly. Patients using marijuana outside a state-licensed program — including those sourcing from caregivers or informal markets — are unaffected by the new form language. Buyers in states without a medical program who use cannabis for self-medication also remain disqualified, even after rescheduling.

The Supreme Court's pending review of United States v. Daniels, which tests whether the federal firearm ban on drug users violates the Second Amendment, is widely expected to reshape this landscape further in the 2026-2027 term.

What This Means for Patients and Dealers

For medical patients, the change does not automatically grant gun-purchase rights — it removes a hostile warning, but the certification question itself still exists. Patients should consult an attorney in their state before answering Question 21.g, particularly in states where medical cannabis registration is shared with law enforcement databases.

For licensed firearms dealers, the revision means new Form 4473 inventory, updated dealer training, and new policies for handling buyers who voluntarily disclose medical cannabis use. ATF has signaled it will publish dealer guidance alongside the final form later this year.

For the cannabis industry, the ATF revision is a tangible, downstream proof point that Schedule III is reshaping federal policy in ways that go far beyond tax treatment under Section 280E. Each agency now has cover — and pressure — to revisit its own marijuana-specific rules.

Key Takeaways

• ATF's draft revised Form 4473, published in May 2026, removes the explicit medical marijuana warning for gun buyers but keeps the broader controlled-substance certification.
• The change is a downstream consequence of the Trump administration's April 23 order moving FDA-approved and state-licensed medical cannabis to Schedule III.
• Recreational cannabis consumers in adult-use states remain federally barred from buying firearms; only state-registered medical patients see meaningful relief.
• Public comments on the proposed form are open through July 7, 2026, with a finalized version expected later this year.
• The Supreme Court's United States v. Daniels case could further reshape the intersection of cannabis use and Second Amendment rights in the coming term.

Whether you are a medical patient navigating the post-rescheduling form 4473 or a recreational consumer in an adult-use state, Budpedia can help you find a dispensary near you at state-licensed medical retailers across every legal jurisdiction, including Florida dispensaries at the center of the cannabis-and-Second-Amendment debate. For deeper context on the parallel court fight, see our breakdown of the DOJ's Supreme Court cannabis gun-rights case.

Explore cannabis news, find dispensaries, and join the community at Budpedia.